Carmen Bozic - 10 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP and CMO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2023
Net transactions value
-$2,285,665
Form type
4
Filing time
14 Feb 2023, 15:55:30 UTC
Previous filing
03 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $796,751 -2,707 -3.5% $294.33 75,257 10 Feb 2023 Direct
transaction VRTX Common Stock Tax liability $1,488,914 -4,992 -6.6% $298.26 70,265 13 Feb 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.